Publication | Open Access

Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation

VaccinationNanomedicineCross-protectionEngineeringPd-1 LigandsImmunologyAntigen Mrna ElectroporationSirna-lipid NanoparticlesTherapeutic VaccineNano-drug DeliveryBiomedical EngineeringVaccine DesignPolyvalent VaccineImmunotherapyMedicine